Skip to main content

. 1995 Mar;95(3):923. doi: 10.1172/JCI117798

The potential significance of beta 3 adrenergic receptors.

B B Lowell, J S Flier

PMCID: PMC441421 PMID: 7883990

923

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Arch J. R., Kaumann A. J. Beta 3 and atypical beta-adrenoceptors. Med Res Rev. 1993 Nov;13(6):663–729. doi: 10.1002/med.2610130604. [DOI] [PubMed] [Google Scholar]
Emorine L. J., Marullo S., Briend-Sutren M. M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A. D. Molecular characterization of the human beta 3-adrenergic receptor. Science. 1989 Sep 8;245(4922):1118–1121. doi: 10.1126/science.2570461. [DOI] [PubMed] [Google Scholar]
Emorine L., Blin N., Strosberg A. D. The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci. 1994 Jan;15(1):3–7. doi: 10.1016/0165-6147(94)90118-x. [DOI] [PubMed] [Google Scholar]
Lowell B. B., S-Susulic V., Hamann A., Lawitts J. A., Himms-Hagen J., Boyer B. B., Kozak L. P., Flier J. S. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 1993 Dec 23;366(6457):740–742. doi: 10.1038/366740a0. [DOI] [PubMed] [Google Scholar]
Lönnqvist F., Thöme A., Nilsell K., Hoffstedt J., Arner P. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest. 1995 Mar;95(3):1109–1116. doi: 10.1172/JCI117758. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES